Summary
The paper discusses the current status and challenges of neuroprotective strategies for retinal ganglion cell degeneration, focusing on the role of retinal ganglion cells (RGCs) in the retina and the brain, and the potential for therapies directed at RGCs to prevent the progression of optic neuropathies.
Categories
Eye health: The paper discusses the role of retinal ganglion cells (RGCs) in the retina and the brain, and the potential for therapies directed at RGCs to prevent the progression of optic neuropathies.
Aging: The paper discusses how the ability of RGCs to extend their axons decreases with age and the capacity to regenerate their axons is lost early in development.
Author(s)
R Boia, N Ruzafa, ID Aires, X Pereiro
Publication Year
2020
Number of Citations
86
Related Publications
Eye health
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Strange vision: ganglion cells as circadian photoreceptors
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Combinatorial effects of alpha-and gamma-protocadherins on neuronal survival and dendritic self-avoidance
- Quadrant field pupillometry detects melanopsin dysfunction in glaucoma suspects and early glaucoma